JPH0459285B2 - - Google Patents

Info

Publication number
JPH0459285B2
JPH0459285B2 JP62024391A JP2439187A JPH0459285B2 JP H0459285 B2 JPH0459285 B2 JP H0459285B2 JP 62024391 A JP62024391 A JP 62024391A JP 2439187 A JP2439187 A JP 2439187A JP H0459285 B2 JPH0459285 B2 JP H0459285B2
Authority
JP
Japan
Prior art keywords
skin
formula
fatty acid
cholesterol
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62024391A
Other languages
Japanese (ja)
Other versions
JPS63192703A (en
Inventor
Yoshitaka Yoda
Masahiko Asahi
Toshuki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2439187A priority Critical patent/JPS63192703A/en
Priority to ES8800292A priority patent/ES2013792A6/en
Publication of JPS63192703A publication Critical patent/JPS63192703A/en
Publication of JPH0459285B2 publication Critical patent/JPH0459285B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides

Description

【発明の詳細な説明】[Detailed description of the invention]

〔産業上の利用分野〕 本発明は皮膚外用剤、更に詳しくは、角層の水
分保持力を高め、肌あれを改善することのできる
皮膚外用剤に関する。 〔従来の技術〕 従来、肌にうるおいを与え、肌を柔軟にするに
は、角質層の水分が重要であることが知られてい
る。そして、当該水分の保持は、角質層に含まれ
ている水溶性成分、すなわち遊離アミノ酸、有機
酸、尿素又は無機イオンによるものであるとさ
れ、これらの物質は単独であるいは組合せて薬用
皮膚外用剤あるいは化粧料に配合して、肌あれの
改善又は予防の目的で使用されている。 また、これとは別に水と親和性が高い多くの保
湿性物質が開発され、同様の目的で使用されてい
る。 〔発明が解決しようとする問題点〕 しかしながら、これらの保湿性物質は、皮膚に
適用した場合、その作用は、皮膚角質上にあつて
水分を角質に供給するというもので、しかもその
効果は一時的であり、根本的に角質層の水分保持
能力を改善し、肌あれを本質的に予防あるいは治
癒させるというものではなかつた。 〔問題点を解決するための手段〕 斯かる実情において、本発明者らは上記問題点
を解決すべく角質細胞間脂質に注目して鋭意研究
を行つたところ、大量に入手の容易な下記一般式
()で表わされる新規アミド誘導体及び角質細
胞間に存在する脂質で組合せたものが角質層の水
分保持能力を根本的に改善する効果を奏するこ
と、そして上記混合物に界面活性剤を併用すると
その効果を更に増大できることを見出し、本発明
を完成した。 すなわち、本発明は次の成分(A)及び(B) (A) 一般式() (式中、R3は炭素数10〜26の直鎖若しくは
分岐鎖の飽和若しくは不飽和の炭化水素基、
R4は炭素数9〜25の直鎖若しくは分岐鎖の飽
和若しくは不飽和の炭化水素基を示す) で表わされるアミド誘導体の一種又は二種以
上、 (B) コレステロール、コレステロール脂肪酸エス
テル、脂肪酸、トリグリセリド、セレブロシド
又はリン脂質の一種又は二種以上、 を含有することを特徴とする皮膚外用剤を提供す
るものである。 本発明で使用されるアミド誘導体()は新規
な化合物であるが、公知の方法〔例えば、ポリツ
シユ・ジヤーナル・オブ・ケミストリー(Pol.J.
Chem.)52,1059(1978);同52,1283(1978);特
開昭54−117421号、同54−144308号、同54−
147937号公報〕に準じて製造することができる。
すなわち、次に示される反応式に従つて、グリシ
ジルエーテルとエタノールアミンから得られる化
合物()を脂肪酸メチルエステルと反応させる
ことによつて製造することができる。 (式中、R3及びR4は前記と同じ) このようにアミド誘導体()は、安価かつ入
手の容易な原料から簡便かつ大量に製造すること
ができる。 コレステロールとしては、次式() で表わされるものが最も好ましいが、3位水酸基
が残存しているものであれば如何なる誘導体も使
用できる。 コレステロール脂肪酸エステルとしては、式
() (式中、R5は1個以上の水酸基が置換するこ
とのある炭素数1〜25の直鎖若しくは分岐鎖の飽
和若しくは不飽和の炭化水素基を示す) で表わされるものが最も好ましいが、3位エステ
ル基が残存しているものであれば如何なる誘導体
も使用できる。 脂肪酸としては一般式() R6−COOH () (式中、R6は1個以上の水酸基が置換するこ
とのある炭素数1〜25の直鎖若しくは分岐鎖の飽
和若しくは不飽和の炭化水素基を示す) で表わされるものが使用できるが、炭素数14〜18
の直鎖の飽和若しくは不飽和の脂肪酸が最適であ
る。 トリグリセリドとしては一般式() (式中、R7,R8,R9は1個以上の水酸基が置
換することのある炭素数1〜25の直鎖若しくは分
岐鎖の飽和若しくは不飽和の炭化水素基を示す) で表わされるものが使用できる。 セレブロシドは、セラミドに糖が付加した複合
脂質であり、一般式() (式中、Xはグルコース、ラクトース等の糖を
示し、R1及びR2は1個以上の水酸基が置換する
ことのある炭素数10〜26の直鎖若しくは分岐鎖の
飽和若しくは不飽和の炭化水素基を示す) で表わされる。 リン脂質には、大別するとグリセリン誘導体で
あるグリセロリン脂質とセラミド誘導体であるス
フインゴリン脂質があるが、本発明にはその何れ
に含まれるものも使用できる。 本発明の皮膚外用剤への(A)成分及び(B)成分の配
合比は、重量比で8:2〜2:8が好ましい。こ
れらを配合するには、両者を上記比率で混合して
一旦加熱溶解後冷却してペースト状あるいは固体
状としたものを他の成分に添加するのが好ましい
が、またそれぞれを別個に添加してもよい。 成分(A)と成分(B)の混合物の本発明皮膚外用剤へ
の配合量は、特に制限されないが、通常乳化型の
皮膚外用剤の場合には全組成の0.01〜60重量%
(以下単に%で示す)、特に0.1〜30%が好ましく、
またスクワラン等の液状炭化水素を基剤とする油
性の皮膚外用剤の場合には1〜90%、特に5〜50
%が好ましい。 本発明の効果を更に増大するために併用される
界面活性剤としては、非イオン界面活性剤、陰イ
オン界面活性剤、両性界面活性剤の何れをも使用
できるが、就中非イオン界面活性剤が好適であ
る。 非イオン界面活性剤としては、例えばポリオキ
シエチレンアルキルエーテル、ポリオキシエチレ
ンアルキルフエニルエーテル、ポリオキシエチレ
ン脂肪酸エステル、ソルビタン脂肪酸エステル、
ポリオキシエチレンソルビタン脂肪酸エステル、
脂肪酸モノグリセライド、グリセリルエーテル等
が挙げられる。その中でも、次の一般式() (式中、R10は炭素数8〜24のアルキル基を示
す) で表わされるグリセリルエーテル、就中R10が次
式() (式中、pは4〜10の整数、qは5〜11の整数
を示し、p+q=11〜17でp=7、q=8を頂点
とする分布を有する) で表わされるものが特に好ましい。 界面活性剤の配合量は、全組成の0.01〜20%、
特に0.1〜5%が好ましい。 本発明の皮膚外用剤は、その使用形態におい
て、薬用皮膚外用剤と化粧料に大別される。 薬用皮膚外用剤としては、例えば薬効成分を含
有する各種軟膏剤を挙げることができる。軟膏剤
としては、油性基剤をベースとするもの、油/
水、水/油型の乳化系基剤をベースとするものの
いずれであつてもよい。油性基剤としては、特に
制限はなく、例えば植物油、動物油、合成油、脂
肪酸、及び天然又は合成のグリセライド等が挙げ
られる。また薬効成分としては、特に制限はな
く、例えば鎮痛消炎剤、鎮痒剤、殺菌消毒剤、収
斂剤、皮膚軟化剤、ホルモン剤等を必要に応じて
適宜使用することができる。 また、化粧料として使用する場合は、必須成分
の他に化粧料成分として一般に使用されている油
分、保湿剤、紫外線吸収剤、アルコール類、キレ
ート類、PH調整剤、防腐剤、増粘剤、色素、香料
等を任意に組合せて配合することができる。 化粧料としては、種々の形態、例えば水/油、
油/水型乳化化粧料、クリーム、化粧乳液、化粧
水、油性化粧料、口紅、フアウンデーシヨン、皮
膚洗浄剤、ヘアートニツク、整髪剤、養毛剤、育
毛剤等の皮膚化粧料とすることができる。 〔作用〕 本発明皮膚外用剤における、成分(A)と成分(B)の
混合物の作用機構の詳細は完全には解明されてい
ないが、これが角質細胞間で水とともに脂質2重
層を構築して、角質層の水分保持機能を発揮する
ものと考えられる。 〔発明の効果〕 本発明皮膚外用剤は、このような作用を有する
成分(A)と成分(B)の混合物を含有するものであるた
め、肌あれに対して優れた改善及び予防効果を発
揮することができる。 〔実施例〕 次に参考例及び実施例を挙げて説明する。 参考例 1 N−(2−ヒドロキシ−3−ヘキサデシロキシ
プロピル)−N−2−ヒドロキシエチルヘキサ
デカナミド〔式()において、R3=C16H33
R4=C15H31のもの〕(a)の合成: 撹拌装置、滴下漏斗、温度計、還流冷却器およ
び窒素導入管を備えた54ツ口フラスコにエタ
ノールアミン1637g(26.8モル)および、エタノ
ール327g(7.11モル)を入れ、窒素雰囲気下で
80℃に加熱撹拌しつつ、これにヘキサデシルグリ
シジルエーテル400g(1.34モル)を3時間かけ
て滴下した。滴下終了後、更に同条件下30分間加
熱撹拌したのち、蒸留装置をとりつけ、エタノー
ルおよび、未反応のエタノールアミンを減圧下に
留去(79〜81℃/20Torr)した。80℃/20Torr
で加熱撹拌しつつ、これに、ヘキサデカン酸メチ
ル362.3g(1.34モル)を3時間かけて滴下した。
滴下終了後、更に同条件下、1時間加熱撹拌する
ことにより、淡黄色の粗生成物801gを得た。こ
れをヘキサンから1回、エタノールから2回再結
晶することにより、無色粉末の目的化合物(
a)649g(収率81%)を得た。 実施例 1 成分(A)と成分(B)の混合物の調製: 化合物(a)を60重量%、コレステロール
〔式()〕を40重量%となるようにガラスネジ口
のサンプル瓶に計量する。サンプル瓶をヒーテイ
ング・ブロツク等を用いて150℃となるように加
熱する。加熱して(a)及びコレステロールが
完全に溶解したら、加熱を終了し、空気中で放冷
してペースト状態の混合物を得る。 実施例 2 ワセリンに実施例1で得た混合物を(a)が
15重量%、コレステロールが10重量%になるよう
に添加配合して調製した皮膚外用剤(本発明品
1)、ワセリンに上記混合物を(a)が15重量
%、コレステロールが10重量%になるように加
え、更にグリセリルエーテル〔式()中R10
式()のもの〕4重量%を配合して調製した皮
膚外用剤(本発明品2)、並びにワセリン(対照)
を用い、下記方法により皮膚コンダクタンス及び
肌あれについて評価した。結果を第1表に示す。 (試験方法) 冬期に頬部に肌あれを起こしている20〜〜50才
の女性10名を被験者とし、左右の頬に異なるサン
プルを毎日1回2週間塗布する。2週間の塗布が
終了した翌日に次の項目につき試験を行なつた。 (1) 皮膚コンダクタンス 37℃の温水にて洗顔後、温度20℃、湿度40%の
部屋で20分間安静にした後、角質層の水分含有量
を皮膚コンダクタンスメーター(IBS社製)にて
測定した。コンダクタンス値は値が小さいほど皮
膚は肌あれし、5以下ではひどい肌あれである。
一方この値が20以上であれば肌あれはほとんど認
められない。 (2) 肌あれスコア 肌あれを肉眼で観測し、下記基準により判定し
た。スコアは平均値±標準偏差で示した。
[Industrial Field of Application] The present invention relates to a skin preparation for external use, and more particularly, to a skin preparation for external use that can improve the moisture retention capacity of the stratum corneum and improve rough skin. [Prior Art] It has been known that the moisture in the stratum corneum is important for moisturizing the skin and making it soft. The retention of moisture is said to be due to water-soluble components contained in the stratum corneum, such as free amino acids, organic acids, urea, or inorganic ions, and these substances may be used alone or in combination in medicated skin preparations. Alternatively, it is used in cosmetics to improve or prevent rough skin. In addition, many other moisturizing substances that have a high affinity for water have been developed and are used for similar purposes. [Problem to be solved by the invention] However, when these moisturizing substances are applied to the skin, their action is to supply moisture to the stratum corneum on the skin, and the effect is temporary. However, it did not fundamentally improve the water retention ability of the stratum corneum or essentially prevent or cure rough skin. [Means for Solving the Problems] Under these circumstances, the present inventors conducted intensive research focusing on interkeratinocyte lipids in order to solve the above problems, and found that the following general lipids, which are easily available in large quantities, The combination of the novel amide derivative represented by the formula () and the lipid present between corneocytes has the effect of fundamentally improving the water retention ability of the stratum corneum, and that the combination of the above mixture with a surfactant improves the water retention ability of the stratum corneum. They discovered that the effect could be further increased and completed the present invention. That is, the present invention comprises the following components (A) and (B) (A) General formula () (In the formula, R 3 is a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms,
( R4 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms); (B) cholesterol, cholesterol fatty acid ester, fatty acid, triglyceride; The present invention provides an external skin preparation characterized by containing one or more of , cerebroside, or phospholipid. Although the amide derivative () used in the present invention is a new compound, it can be obtained by a known method [for example, Polytechnic Journal of Chemistry (Pol.J.
Chem.) 52 , 1059 (1978); 52 , 1283 (1978); JP 54-117421, 54-144308, 54-
147937].
That is, it can be produced by reacting a compound () obtained from glycidyl ether and ethanolamine with a fatty acid methyl ester according to the reaction formula shown below. (In the formula, R 3 and R 4 are the same as above.) In this way, the amide derivative () can be easily produced in large quantities from inexpensive and easily available raw materials. For cholesterol, the following formula () The derivative represented by is most preferred, but any derivative can be used as long as the hydroxyl group at the 3-position remains. For cholesterol fatty acid ester, the formula () (In the formula, R 5 represents a straight chain or branched chain saturated or unsaturated hydrocarbon group having 1 to 25 carbon atoms which may be substituted with one or more hydroxyl groups). Any derivative can be used as long as the 3-position ester group remains. The fatty acid has the general formula () R 6 -COOH () (where R 6 is a linear or branched saturated or unsaturated hydrocarbon having 1 to 25 carbon atoms that may be substituted with one or more hydroxyl groups). (representing a group) can be used, but those having 14 to 18 carbon atoms can be used.
Straight chain saturated or unsaturated fatty acids are most suitable. General formula () for triglyceride (In the formula, R 7 , R 8 , and R 9 represent a straight chain or branched chain saturated or unsaturated hydrocarbon group having 1 to 25 carbon atoms that may be substituted with one or more hydroxyl groups.) Things can be used. Cerebroside is a complex lipid made by adding sugar to ceramide, and has the general formula () (In the formula , (represents a hydrogen group). Phospholipids can be broadly classified into glycerophospholipids, which are glycerin derivatives, and sphingophospholipids, which are ceramide derivatives. Phospholipids included in either of these can be used in the present invention. The blending ratio of component (A) and component (B) in the external skin preparation of the present invention is preferably 8:2 to 2:8 by weight. To blend these, it is preferable to mix both in the above ratio, heat and melt, then cool to form a paste or solid, which is then added to the other ingredients, but it is also preferable to add each separately. Good too. The amount of the mixture of component (A) and component (B) in the skin preparation of the present invention is not particularly limited, but in the case of an emulsion-type skin preparation, it is usually 0.01 to 60% by weight of the total composition.
(hereinafter simply expressed as %), particularly preferably 0.1 to 30%,
In the case of oil-based external skin preparations based on liquid hydrocarbons such as squalane, 1 to 90%, especially 5 to 50%
% is preferred. As the surfactant used in combination to further increase the effects of the present invention, any of nonionic surfactants, anionic surfactants, and amphoteric surfactants can be used, but especially nonionic surfactants is suitable. Examples of nonionic surfactants include polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene fatty acid ester, sorbitan fatty acid ester,
polyoxyethylene sorbitan fatty acid ester,
Examples include fatty acid monoglyceride and glyceryl ether. Among them, the following general formula () (In the formula, R 10 represents an alkyl group having 8 to 24 carbon atoms) Glyceryl ether represented by the following formula () (In the formula, p is an integer of 4 to 10, q is an integer of 5 to 11, and has a distribution where p+q=11 to 17, with p=7 and q=8 as the vertices) . The amount of surfactant added is 0.01 to 20% of the total composition.
Particularly preferred is 0.1 to 5%. The skin external preparations of the present invention are broadly classified into medicated skin external preparations and cosmetics in terms of their usage forms. Examples of medicated skin external preparations include various ointments containing medicinal ingredients. Ointments include those based on oily bases, oil/
It may be based on water or water/oil type emulsion base. The oily base is not particularly limited and includes, for example, vegetable oils, animal oils, synthetic oils, fatty acids, natural or synthetic glycerides, and the like. There are no particular limitations on the medicinal ingredients, and for example, analgesic and antiinflammatory agents, antipruritic agents, sterilizing disinfectants, astringents, emollients, hormonal agents, and the like can be used as appropriate. When used as a cosmetic, in addition to the essential ingredients, oils, moisturizers, ultraviolet absorbers, alcohols, chelates, PH adjusters, preservatives, thickeners, Any combination of dyes, fragrances, etc. can be blended. Cosmetics can be used in various forms, such as water/oil,
It can be used as skin cosmetics such as oil/water type emulsified cosmetics, creams, cosmetic emulsions, lotions, oil-based cosmetics, lipsticks, foundations, skin cleansers, hair tonics, hair conditioners, hair tonics, hair growth agents, etc. . [Action] Although the details of the mechanism of action of the mixture of component (A) and component (B) in the topical skin preparation of the present invention have not been completely elucidated, it is believed that it builds a lipid bilayer together with water between corneocytes. It is thought that it exerts the moisture retention function of the stratum corneum. [Effects of the Invention] Since the skin external preparation of the present invention contains a mixture of component (A) and component (B) that have the above-mentioned effects, it exhibits excellent improvement and prevention effects on rough skin. can do. [Example] Next, reference examples and examples will be given and explained. Reference Example 1 N-(2-hydroxy-3-hexadecyloxypropyl)-N-2-hydroxyethylhexadecanamide [In formula (), R 3 = C 16 H 33 ,
R 4 = C 15 H 31 ] Synthesis of (a): 1637 g (26.8 mol) of ethanolamine and ethanol were placed in a 54-necked flask equipped with a stirrer, a dropping funnel, a thermometer, a reflux condenser, and a nitrogen inlet tube. 327g (7.11mol) was added under nitrogen atmosphere.
While heating and stirring at 80°C, 400 g (1.34 mol) of hexadecyl glycidyl ether was added dropwise over 3 hours. After completion of the dropwise addition, the mixture was further heated and stirred for 30 minutes under the same conditions, and then a distillation apparatus was attached, and ethanol and unreacted ethanolamine were distilled off under reduced pressure (79-81°C/20 Torr). 80℃/20Torr
While heating and stirring, 362.3 g (1.34 mol) of methyl hexadecanoate was added dropwise to this over 3 hours.
After the addition was completed, the mixture was further heated and stirred for 1 hour under the same conditions to obtain 801 g of a pale yellow crude product. By recrystallizing this once from hexane and twice from ethanol, the target compound (
a) 649 g (yield 81%) was obtained. Example 1 Preparation of a mixture of components (A) and (B): 60% by weight of compound (a) and 40% by weight of cholesterol [formula ()] are weighed into a glass screw cap sample bottle. Heat the sample bottle to 150℃ using a heating block, etc. When (a) and cholesterol are completely dissolved by heating, the heating is terminated and the mixture is left to cool in the air to obtain a paste-like mixture. Example 2 The mixture obtained in Example 1 was added to petrolatum (a).
A skin external preparation prepared by adding and blending the above mixture to Vaseline so that the amount of (a) is 15% by weight and the cholesterol is 10% by weight (product 1 of the present invention). In addition to this, a skin external preparation prepared by adding 4% by weight of glyceryl ether [in which R 10 is of the formula ()] (invention product 2), and vaseline (control)
The skin conductance and skin roughness were evaluated using the following method. The results are shown in Table 1. (Test method) Ten women between the ages of 20 and 50 who suffer from rough skin on their cheeks during the winter were used as subjects, and different samples were applied to the left and right cheeks once a day for two weeks. The next day after the two-week application was completed, the following tests were conducted. (1) Skin conductance After washing the face with warm water at 37℃ and resting for 20 minutes in a room with a temperature of 20℃ and humidity of 40%, the water content of the stratum corneum was measured using a skin conductance meter (manufactured by IBS). . As for the conductance value, the smaller the value, the rougher the skin, and if it is less than 5, the skin is severely rough.
On the other hand, if this value is 20 or higher, skin roughness is hardly observed. (2) Skin roughness score Skin roughness was observed with the naked eye and judged according to the following criteria. Scores were expressed as mean value ± standard deviation.

【表】 (結果)【table】 (result)

【表】 実施例 3 化合物(a)と、式()で示されるコレス
テロールと、ステアリン酸〔式()で、R6
C17H33のもの〕を第2表に示すように配合した
水中油型乳化化粧料を製造し、実施例2と同様な
方法を用いて、皮膚コンダクタンス及び肌あれに
ついて評価した。結果を第3表に示す。
[Table] Example 3 Compound (a), cholesterol represented by formula (), and stearic acid [in formula (), R 6 =
C 17 H 33 ] was formulated as shown in Table 2 to produce an oil-in-water emulsion cosmetic, and using the same method as in Example 2, skin conductance and skin roughness were evaluated. The results are shown in Table 3.

【表】【table】

【表】 実施例 4 化粧料(乳液) <組成> 油相成分: マカデミアンナツツ油 2.0(重量%) スクワラン 5.0 ステアリン酸 1.0 化合物(a) 1.0 大豆リン脂質 0.5 グルコセレブロシド(牛脳抽出物)
0.5 モノステアリン酸ソルビタン 0.5 POE(60)硬化ヒマシ油 1.0 水相成分: グリセリン 1.0 プロピレングリコール 1.0 メチルパラベン 0.3 香 料 0.1 精製水 全体を100とする量 <製造法> 油相成分を混合し、加熱溶解して70℃に保つ。
水相成分も同様に70℃で加熱混合し、この水相成
分に前述の油相部を加えて乳化機にて乳化する。
乳化物を熱交換機にて終温30℃まで冷却したのを
容器に充填して乳液を調製した。
[Table] Example 4 Cosmetic (emulsion) <Composition> Oil phase components: Macadamia nut oil 2.0 (wt%) Squalane 5.0 Stearic acid 1.0 Compound (a) 1.0 Soybean phospholipid 0.5 Glucocerebroside (cow brain extract)
0.5 Sorbitan monostearate 0.5 POE (60) hydrogenated castor oil 1.0 Water phase components: Glycerin 1.0 Propylene glycol 1.0 Methylparaben 0.3 Fragrance 0.1 Purified water Amount to make the total 100 <Manufacturing method> Mix the oil phase components and heat and dissolve. and keep at 70℃.
The aqueous phase components are similarly heated and mixed at 70°C, and the above-mentioned oil phase is added to the aqueous phase components and emulsified using an emulsifier.
The emulsion was cooled to a final temperature of 30°C using a heat exchanger and then filled into a container to prepare an emulsion.

Claims (1)

【特許請求の範囲】 1 次の成分(A)及び(B)、 (A) 一般式() (式中、R3は炭素数10〜26の直鎖若しくは
分岐鎖の飽和若しくは不飽和の炭化水素基、
R4は炭素数9〜25の直鎖若しくは分岐鎖の飽
和若しくは不飽和の炭化水素基を示す) で表わされるアミド誘導体の一種又は二種以
上、 (B) コレステロール、コレステロール脂肪酸エス
テル、脂肪酸、トリグリセリド、セレブロシド
又はリン脂質の一種又は二種以上、 を含有することを特徴とする皮膚外用剤。 2 (A)成分と(B)成分の配合比が、重量比で8:2
〜2:8である特許請求の範囲第1項記載の皮膚
外用剤。 3 更に界面活性剤を含有する特許請求の範囲第
1項記載の皮膚外用剤。
[Claims] 1st order components (A) and (B), (A) General formula () (In the formula, R 3 is a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms,
( R4 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms); (B) cholesterol, cholesterol fatty acid ester, fatty acid, triglyceride; , one or more types of cerebrosides or phospholipids. 2 The blending ratio of component (A) and component (B) is 8:2 by weight.
The skin external preparation according to claim 1, wherein the ratio is 2:8. 3. The external preparation for skin according to claim 1, further comprising a surfactant.
JP2439187A 1987-02-04 1987-02-04 External agent for skin Granted JPS63192703A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2439187A JPS63192703A (en) 1987-02-04 1987-02-04 External agent for skin
ES8800292A ES2013792A6 (en) 1987-02-04 1988-02-02 External agent for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2439187A JPS63192703A (en) 1987-02-04 1987-02-04 External agent for skin

Publications (2)

Publication Number Publication Date
JPS63192703A JPS63192703A (en) 1988-08-10
JPH0459285B2 true JPH0459285B2 (en) 1992-09-21

Family

ID=12136865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2439187A Granted JPS63192703A (en) 1987-02-04 1987-02-04 External agent for skin

Country Status (2)

Country Link
JP (1) JPS63192703A (en)
ES (1) ES2013792A6 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871974T2 (en) * 1987-02-12 1993-01-14 Estee Lauder Inc HAIR PROTECTIVE AGENT AND METHOD.
US5087418A (en) * 1987-02-25 1992-02-11 Adir Jacob Process for dry sterilization of medical devices and materials
JPH0366604A (en) * 1989-08-04 1991-03-22 Kanebo Ltd Dermal cosmetic
JPH0647528B2 (en) * 1990-03-07 1994-06-22 キユーピー株式会社 Cosmetics
US5565207A (en) * 1990-09-19 1996-10-15 Pola Kasei Kogyo Kabushiki Kaisha Scalp moisturizer and external skin preparation
JP2931708B2 (en) * 1991-07-18 1999-08-09 ポーラ化成工業株式会社 Hair restoration
AU639373B2 (en) * 1990-10-22 1993-07-22 Unilever Plc Cosmetic composition
GB9100816D0 (en) * 1991-01-15 1991-02-27 Unilever Plc Cosmetic composition
FR2675045A1 (en) * 1991-04-10 1992-10-16 Carita Sa Cosmetic composition having an antidehydrating effect which is usable in lipsticks
CA2087691A1 (en) * 1992-01-23 1993-07-24 Peter Critchley Cosmetic compositon
US5372814A (en) * 1992-02-05 1994-12-13 Kao Corporation Sterol derivative, process for producing the same and dermatologic external preparation
FR2690343B1 (en) * 1992-04-28 1995-09-01 Inocosm Laboratoires ANTI-RADICAL AND ANTI-LIPOPEROXIDANT COMPOSITION.
WO1994000127A1 (en) * 1992-06-19 1994-01-06 The Regents Of The University Of California Lipids for epidermal moisturization and repair of barrier function
GB9308103D0 (en) * 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
US5368857A (en) * 1993-11-15 1994-11-29 Elizabeth Arden Company, Division Of Conopco, Inc. Ceramide cosmetic compositions
WO1995029151A1 (en) * 1994-04-27 1995-11-02 Gist-Brocades B.V. Short chain 2-hydroxycarboxylic acid-based derivatives of ceramides
GB9421185D0 (en) * 1994-10-20 1994-12-07 Unilever Plc Personal car composition
JPH09508925A (en) * 1994-11-28 1997-09-09 ギスト ブロカデス ベスローテン フェンノートシャップ Topical application of ceramides
FR2730410B1 (en) * 1995-02-15 1997-03-21 Oreal COSMETIC COMPOSITION COMPRISING A COMBINATION OF CERAMIDES AND ITS USE
TW453881B (en) * 1995-10-16 2001-09-11 Kao Corp Cosmetic composition comprising amide derivatives
EP0866693B1 (en) * 1995-10-18 2003-08-20 Mary Kay Inc. Topically applied, structural cellulite treatments
US5571518A (en) 1995-10-30 1996-11-05 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing tricholine citrate
US5667770A (en) * 1996-03-25 1997-09-16 Elizabeth Arden Company, Division Of Conopco, Inc. Long wearing lipstick
KR19980034991A (en) 1996-11-11 1998-08-05 안용찬 Non-natural ceramide-related compounds and external skin preparations containing them
CO5111023A1 (en) 1998-12-31 2001-12-26 Kimberly Clark Co COMPOSITION OF ABSORBENT ARTICLE AND METHOD FOR USE TO SEQUEST SKIN IRRITANTS
KR100371491B1 (en) * 1999-07-27 2003-02-07 주식회사 두산 Cream Composition For Skin Care
JP4780817B2 (en) * 2000-02-07 2011-09-28 株式会社ノエビア Epidermis ceramide production promoter and epidermis moisturizing function improving agent containing the same
JP4350269B2 (en) 2000-05-11 2009-10-21 高砂香料工業株式会社 Cosmetic additive composition
WO2003049709A1 (en) 2001-12-10 2003-06-19 Kao Corporation Ceramide emulsions
TW200413020A (en) * 2002-07-05 2004-08-01 Kose Corp Vesicle dispersion and cosmetic containing the same
AU2003277638A1 (en) * 2002-11-15 2004-06-15 Kose Corporation Semitransparent cosmetics
JP2006273747A (en) * 2005-03-29 2006-10-12 Kose Corp O/w/o type emulsion cosmetic
JP2007001950A (en) * 2005-06-27 2007-01-11 Pola Chem Ind Inc Ceramide-containing skin external preparation
CN101677926B (en) * 2007-03-01 2012-06-06 高砂香料工业株式会社 Lipid composition having excellent shape retention property and product
JP4825981B2 (en) * 2007-03-27 2011-11-30 大学共同利用機関法人自然科学研究機構 Waveguide junction
JP5432470B2 (en) * 2007-05-01 2014-03-05 株式会社ファンケル Ceramide solution and external preparation for skin
JP6040079B2 (en) * 2013-03-28 2016-12-07 花王株式会社 Method for producing amide derivative
JP6564223B2 (en) * 2015-03-31 2019-08-21 小林製薬株式会社 Composition for external use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271205A (en) * 1985-05-24 1986-12-01 Kanebo Ltd Skin cosmetic
JPS61289013A (en) * 1985-06-18 1986-12-19 Pola Chem Ind Inc Skin external agent
JPS63141908A (en) * 1986-12-03 1988-06-14 Kanebo Ltd Emulsion-type cosmetic

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271205A (en) * 1985-05-24 1986-12-01 Kanebo Ltd Skin cosmetic
JPS61289013A (en) * 1985-06-18 1986-12-19 Pola Chem Ind Inc Skin external agent
JPS63141908A (en) * 1986-12-03 1988-06-14 Kanebo Ltd Emulsion-type cosmetic

Also Published As

Publication number Publication date
JPS63192703A (en) 1988-08-10
ES2013792A6 (en) 1990-06-01

Similar Documents

Publication Publication Date Title
JPH0459285B2 (en)
EP0534286A1 (en) External skin care preparation
WO2000061097A1 (en) External preparation compositions
JPH048104B2 (en)
JPS6027646B2 (en) cosmetics
JPH04112810A (en) Aqueous cosmetic and production thereof
JPH024335B2 (en)
JPS63192704A (en) Cosmetic
JPH0142934B2 (en)
CN106413681A (en) Ceramide-formulated external agent composition
JPS61204109A (en) Emulsion-type composition for external use
JPS60184005A (en) Cosmetic for preventing aging of skin
JP7126753B2 (en) Skin topical agent
JP4112741B2 (en) Moisturizer
JPH0669532B2 (en) Oil-in-water emulsion composition
JPH0316172B2 (en)
JPH05213731A (en) Skin external agent
JP3522794B2 (en) External preparation for skin
JPH06157276A (en) Skin external preparation
JP7126754B2 (en) Skin topical agent
JPS63227513A (en) Dermatic drug for external application
JPS62132808A (en) Hair-forming, hair-growing agent
JPH0565485B2 (en)
JPH07106974B2 (en) Topical skin
JP3462332B2 (en) Oil gelling agent and cosmetic containing the same

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term